Precigen, Inc. Common Stock (PGEN) is a publicly traded Healthcare sector company. As of July 21, 2026, PGEN trades at $5.51 with a market cap of $1.81B and a P/E ratio of -4.03. PGEN moved +8.19% today. Year to date, PGEN is +31.34%; over the trailing twelve months it is +200.00%. Its 52-week range spans $0.65 to $6.04. Analyst consensus is buy with an average price target of $12.50. Rallies surfaces PGEN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for PGEN shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $5.51 |
| Market Cap | $1.81B |
| P/E Ratio | -4.03 |
| EPS | $-1.37 |
| Dividend Yield | 0.00% |
| 52-Week High | $6.04 |
| 52-Week Low | $0.65 |
| Volume | 3.92M |
| Avg Volume | 0 |
| Revenue (TTM) | $9.68M |
| Net Income | $-250.64M |
| Gross Margin | 0.00% |
2 analysts cover PGEN: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $12.50.